• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store

Eleven Things Labs Must Know to Comply with PAMA

by Diana Voorhees, MA, MLS(ASCP)SH, CLCP, CPCO | Jan 27, 2023 | Essential, Lab Compliance Advisor, Legislation-lca

An overview of PAMA and key aspects lab compliance officers should be aware of to help ensure compliance.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here

COVID-19, Genetic Tests Wipe Out Medicare Part B Lab Test Savings

by Glenn S. Demby | Jan 19, 2023 | Essential, National Lab Reporter, Reimbursement-nir

Even though PAMA has slashed reimbursement rates for many tests, overall Medicare Part B spending on lab tests continues to increase.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here

Congress Delays Part B Price Cuts but Nixes Long-Term SALSA Solution

by Glenn S. Demby | Jan 19, 2023 | Essential, Legislation-nir, National Lab Reporter

Legislation offering permanent relief from both PAMA price cuts and reporting didn’t make it into the federal spending bill passed Dec. 23.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Hopes for Permanent PAMA Relief Dashed

Hopes for Permanent PAMA Relief Dashed

by Rachel Muenz | Jan 10, 2023 | News, Open Content

Though the federal spending bill passed at the end of December offers another year’s reprieve from PAMA price cuts, SALSA was not included.

PAMA Alert: Hopes for SALSA Relief Die at the Eleventh Hour

PAMA Alert: Hopes for SALSA Relief Die at the Eleventh Hour

by Glenn S. Demby | Jan 3, 2023 | Essential, Laboratory Industry Report, Reimbursement-lir

Congress fails to include SALSA in the omnibus federal government spending bill passed at the end of 2022, but delays PAMA price cuts once again.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
« Older Entries
Next Entries »

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2026 G2Intelligence.com